within Pharmacolibrary.Drugs.ATC.L;

model L01XX40
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 11.6 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 1.25 / 1000000,
    adminCount     = 1,
    Vd             = 0.126,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Omacetaxine mepesuccinate (also known as homoharringtonine) is an alkaloid antineoplastic agent approved for the treatment of chronic myeloid leukemia (CML) in adults with resistance and/or intolerance to two or more tyrosine kinase inhibitors.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported in adult patients with chronic or accelerated phase chronic myeloid leukemia receiving subcutaneous administration.</p><h4>References</h4><ol><li><p>Nijenhuis, CM, et al., &amp; Schellens, JH (2016). Pharmacokinetics and excretion of (14)C-omacetaxine in patients with advanced solid tumors. <i>Investigational new drugs</i> 34(5) 565–574. DOI:<a href=&quot;https://doi.org/10.1007/s10637-016-0360-9&quot;>10.1007/s10637-016-0360-9</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27221729/&quot;>https://pubmed.ncbi.nlm.nih.gov/27221729</a></p></li><li><p>Damlaj, M, et al., &amp; Assouline, SE (2016). A safety evaluation of omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia. <i>Expert opinion on drug safety</i> 15(9) 1279–1286. DOI:<a href=&quot;https://doi.org/10.1080/14740338.2016.1207760&quot;>10.1080/14740338.2016.1207760</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27367461/&quot;>https://pubmed.ncbi.nlm.nih.gov/27367461</a></p></li><li><p>Nijenhuis, CM, et al., &amp; Beijnen, AJ (2016). Metabolite profiling of . <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 46(12) 1122–1132. DOI:<a href=&quot;https://doi.org/10.3109/00498254.2016.1152418&quot;>10.3109/00498254.2016.1152418</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26998885/&quot;>https://pubmed.ncbi.nlm.nih.gov/26998885</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L01XX40;
